E Fund Management Co., Ltd.

SEC CIK: 0001842296
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

SYRE holding history

Spyre Therapeutics, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SYRE overview All 13F holders of SYRE Full Q2 2026 holdings

Shares (Q2 2026): 5,184
Value: $460.2K
% of portfolio: <0.1%
Quarters held: 2; Since Q1 2026

Holdings of SYRE by E Fund Management Co., Ltd., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	5,184	$460.2K	<0.1%	−1,972−27.6%	Reduced	Holders
Q1 2026	7,156	$360.9K	<0.1%	–	No prior filing	Holders